The “infinite energy” secret hiding in the world’s most exclusive vineyards

Last fall, I wrote an article in my Logical Health Alternatives newsletter about a new and exciting supplement called Robuvit®. A couple of months later, I added this unique formula to my Desert Island supplement list. And it has since become one of my go-to recommendations for almost every patient who walks through my office door.

Why the quick rise to fame (in my practice, anyway)?

Because, to-date, it’s the only supplement I’ve ever found that can boost your energy all the way down to the cellular level.

More on that in just a moment, but first, let me tell you a little bit about Robuvit itself…

Robuvit is a patented, all-natural extract from French oak trees. Specifically, it comes from oak trees called Quercus robur, which are grown in France’s Massif Central forests.

This wood is prized among winemakers as the perfect flavor enhancer — so it’s used to build the aging-barrels that store some of the world’s finest wines and spirits.

But these oak trees don’t just enhance the flavor of wine. You see, the wood from these trees contains roburins — a type of flavonoid.

Researchers think roburins might actually change the function of ribosomes, our bodies’ cellular protein factories. Ribosomes help our cells produce energy.

Robuvit has been standardized to contain 20 percent roburins. So it’s no wonder my patients have told me how much better, and more vibrant, they feel after taking it. And their experiences are backed up by some pretty solid clinical research too.

For instance, in one new study, after just four weeks of taking 300 mg of Robuvit per day, 20 participants had a 25 percent improvement in general fatigue. They also had less tiredness and tension. And a significant improvement in energy levels — without side effects.

If all Robuvit could do was reduce fatigue that would still be impressive enough. But with every new study, Robuvit’s potential for your health gets even bigger.

Take a look at some of the recent research…

One study conducted on 91 people found that six months of supplementation with Robuvit (200 mg a day) had a significant impact on mood. In fact, the overall mood score of the Robuvit group rose from -6.9 at the beginning of the study to a whopping +4.3 at the end of the study. Six months later. But the placebo group’s mood only improved from -6.5 to -3.4.

Another small study showed Robuvit can promote healthy homocysteine levels.

Researchers have also found that Robuvit helps promote healthy enzyme levels in the liver and increases albumin levels, which helps promote liver health. And as I’ve mentioned many times before, the liver is one of the most important organs in your body. It helps regulate blood sugar, proteins, and fat in the bloodstream and plays a key role in removing toxins from our blood. It also processes nutrients from the food we eat, produces cholesterol and albumin (an important protein), and breaks down alcohol.

So it’s crucial to take care of your liver. And if the research is any indication, Robuvit may be one of the simplest, most effective ways of doing that.

And yet another study showed that people taking Robuvit had:

  • 29 percent reduction in short-term memory impairment
  • 51 percent reduction in joint discomfort
  • 33 percent fewer headaches
  • 38 percent reduction in dizziness
  • 40 percent less weight fluctuation

And some brand new research showed that Robuvit helped athletes improve their triathlon times. (So just imagine the sort of support it might offer for less intense exercise!)

By now, you can see why Robuvit has cemented a spot on my Desert Island list.

And the more research there is on it, the more it looks like there isn’t anyone who couldn’t benefit from taking it.

So if you haven’t tried Robuvit yet, I urge you to check it out. You can learn more about it or order a supply by clicking here.


Phytother Res. 2015 Aug;29(8):1219-24

Panminerva Med. 2014 Mar;56(1):63-72

Gen Physiol Biophys. 2015 Jan;34(1):73-80

Int J Angiol. 2015 Mar;24(1):47-54

Minerva Cardioangiologica 2015 October;63(5):403-9